Malignant Exocrine Pancreas Neoplasm — Trials

Malignant Exocrine Pancreas Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

930 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 360
Recruiting: 209
Ph III recruiting: 23
Growth YoY: +39.4%
Industry share: 40%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (136)

clinicaltrialsPublishedShowing 201–250 of 930 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07261631	Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors	recruiting	Phase 1	180	Novartis PharmaceuticalsINDUSTRY	6	Jun 17, 2026	clinicaltrials
NCT03269526	BATs Treatment for Pancreatic Cancer, Phase Ib/II	completed	Phase 1 / Phase 2	22	University of VirginiaOTHER	1	Jun 16, 2026	clinicaltrials
NCT05657743